Interaction of candida albicans with an intestinal pathogen, salmonella enterica serovar typhimurium

Eukaryotic Cell

Volumn 8, Issue 5, 2009, Pages 732-737

  Tampakakis, Emmanouil ^a   Peleg, Anton Y ^a,b,c   Mylonakis, Eleftherios ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANTIBIOSIS; ARTICLE; BIOFILM; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; DISEASE MODEL; ENTEROPATHY; HUMAN; INTESTINE; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIBIOSIS; BIOFILMS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; DISEASE MODELS, ANIMAL; HUMANS; INTESTINAL DISEASES; INTESTINES; MICROBIAL VIABILITY; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; EUKARYOTA; NEGIBACTERIA; PROKARYOTA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 66149116045     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00016-09     Document Type: Article

References (23)

1. Aballay, A., P. Yorgey, and F. M. Ausubel 2000. Salmonella typhimuriumproliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr. Biol10:1539-1542.
2. Ahmer, B. M 2004. Cell-to-cell signalling in Escherichia coliand Salmonella enterica. Mol. Microbiol52:933-945.
3. Ahmer, B. M., J. van Reeuwijk, C. D. Timmers, P. J. Valentine, and F. Heffron 1998. Salmonella typhimuriumencodes an SdiA homolog, a putative quorum sensor of the LuxR family, that regulates genes on the virulence plasmid. J. Bacteriol180:1185-1193.
4. Boyle, E. C., J. L. Bishop, G. A. Grassl, and B. B. Finlay 2007. Salmonella: from pathogenesis to therapeutics. J. Bacteriol 189:1489-1495.
5. Braun, B. R., and A. D. Johnson 1997. Control of filament formation in Candida albicansby the transcriptional repressor TUP1. Science 277:105- 109.
6. Breger, J., B. B. Fuchs, G. Aperis, T. I. Moy, F. M. Ausubel, and E. Mylonakis 2007. Antifungal chemical compounds identified using a C. eleganspathogenicity assay. PLoS Pathog3:e18.
7. Chim, H., B. H. Tan, and C. Song 2007. Five-year review of infections in a burn intensive care unit: high incidence of Acinetobacter baumanniiin a tropical climate. Burns 33:1008-1014.
8. Coburn, B., G. A. Grassl, and B. B. Finlay 2007. Salmonella, the host and disease: a brief review. Immunol. Cell Biol85:112-118.
9. Ernst, J. F 2000. Transcription factors in Candida albicans-environmental control of morphogenesis. Microbiology 146:1763-1774.
10. Gudlaugsson, O., S. Gillespie, K. Lee, J. Vande Berg, J. Hu, S. Messer, L. Herwaldt, M. Pfaller, and D. Diekema 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis37:1172-1177.
11. Hogan, D. A., and R. Kolter 2002. Pseudomonas-Candidainteractions: an ecological role for virulence factors. Science 296:2229-2232.
12. Hogan, D. A., A. Vik, and R. Kolter 2004. A Pseudomonas aeruginosaquorum- sensing molecule influences Candida albicansmorphology. Mol. Microbiol54:1212-1223.
13. Kojic, E. M., and R. O. Darouiche 2004. Candida infections of medical devices. Clin. Microbiol. Rev17:255-267.
14. Labrousse, A., S. Chauvet, C. Couillault, C. L. Kurz, and J. J. Ewbank 2000. Caenorhabditis elegansis a model host for Salmonella typhimurium. Curr.Biol10:1543-1545.
15. Liu, H., J. Kohler, and G. R. Fink 1994. Suppression of hyphal formation in Candida albicansby mutation of a STE12 homolog. Science 266:1723-1726.
16. Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink 1997. Nonfilamentous C. albicansmutants are avirulent. Cell 90:939-949.
17. Nobile, C. J., and A. P. Mitchell 2005. Regulation of cell-surface genes and biofilm formation by the C. albicanstranscription factor Bcr1p. Curr. Biol15:1150-1155.
18. Peleg, A. Y., E. Tampakakis, B. B. Fuchs, G. M. Eliopoulos, R. C. Moellering, Jr., and E. Mylonakis 2008. Prokaryote-eukaryote interactions identified byusing Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 105:14585-14590.
19. Richard, M. L., C. J. Nobile, V. M. Bruno, and A. P. Mitchell 2005. Candida albicansbiofilm-defective mutants. Eukaryot. Cell 4:1493-1502.
20. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med27:887-892.
21. Rychlik, I., and P. A. Barrow 2005. Salmonella stress management and its relevance to behaviour during intestinal colonisation and infection. FEMS Microbiol. Rev29:1021-1040.
22. Saville, S. P., A. L. Lazzell, C. Monteagudo, and J. L. Lopez-Ribot 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicansduring infection. Eukaryot. Cell 2:1053-1060.
23. Stecher, B., A. J. Macpherson, S. Hapfelmeier, M. Kremer, T. Stallmach, and W. D. Hardt 2005. Comparison of Salmonella enterica S.Typhimurium colitis in germfree mice and mice pretreated with streptomycin. Infect. Immun73:3228-3241.